SEC Filing Update: #VRDN Viridian Therapeutics, Inc. : $24.30

Sector: Healthcare | YTD: 🔽 -20.80% The SEC disclosed Today (20-AUG-2026) that POINT72 ASSET MANAGEMENT, L P has INCREASED #VRDN Shares by 142.72% 🟢 * Previous Holdings: 2.34M Shares * Current Holdings: 5.69M Shares * Increase+3.34M * Increased(%)+142.72% * Ownership: 5.0% * Estimated Investment Value: $77.65M https://www.thinksabio.com/reports/isr/VRDN Institutional ownership in #VRDN has been steadily rising over the past 4 quarters in Shares: Q3 2025: 93.21M Q4 2025: 107.82M Q1 2026: 112.38M Q2 2026: 127.99M 📌 Institutional activity in the last 30 days for #VRDN: • PRICE T ROWE ASSOCIATES INC MD – Increased holdings by 16 shares (14-AUG-2026) POINT72 ASSET MANAGEMENT, L.P. increased its stake in Viridian Therapeutics (VRDN) from 2,343,208 shares to 5,687,507 shares, representing 5.0% ownership.